| scholarly article | Q13442814 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Barth RJ Jr | |
| Mulé JJ | |||
| Bock SN | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1531-1537 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes | |
| P478 | volume | 144 |
| Q35987503 | A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability |
| Q35024746 | Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. |
| Q53764691 | Adoptive immunotherapy mediated by anti-TCR/IL-2-activated tumour-draining lymph node cells. |
| Q41706966 | Antigen(s)-specific tumour-infiltrating lymphocytes from tumour induced by human herpes virus-6 (HHV-6) DNA transfected NIH 3T3 transformants |
| Q41365438 | Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta |
| Q70577167 | Cure of mice bearing a late-stage, highly metastatic, drug-resistant tumor by adoptive chemoimmunotherapy |
| Q35227334 | Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells |
| Q35945199 | Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response |
| Q36238343 | Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA |
| Q41316596 | Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells |
| Q24678495 | Identification of human cancers deficient in antigen processing |
| Q45160055 | In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions |
| Q71495509 | In vivo effects of locally secreted IL-10 on the murine antitumor immune response |
| Q54241204 | Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking. |
| Q68056499 | Induction of interleukin-2 receptor by tumor necrosis factor alpha on cultured ovarian tumor-associated lymphocytes |
| Q36230021 | Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes |
| Q34667021 | Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses |
| Q36367205 | Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens |
| Q36470715 | Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses |
| Q36610512 | Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin |
| Q34570245 | Progress in the development of immunotherapy for the treatment of patients with cancer |
| Q35018846 | Targeting c-MYC with T-cells |
| Q34553267 | The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists |
| Q45873266 | The development of gene therapy for the treatment of cancer |
| Q33807772 | The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice |
| Q40931125 | The role of the immune system in anti-tumour responses. Potential for drug therapy |
| Q36470718 | Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha |
| Q33993999 | Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure |
| Q70823152 | Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells |
| Q40849487 | Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications |
| Q40146179 | Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection |
| Q35064131 | Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. |
Search more.